What's breaking now, across thousands of outlets.
Vir Biotechnology’s chronic hepatitis D treatment has succeeded in the first of three late-stage studies, stoking competition with Gilead and Mirum Pharmaceuticals. Vir said Sunday afternoon that 44% of patients who received once-monthly tobevibart and ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
American suicide rates have indeed risen since 2000. But they were even higher throughout the first half of the 20th century, and in other countries, suicide rates are decreasing.
(MedPage Today) -- "They have the best of intentions and want to help, but they don't know the questions to ask." -- Anthea Gray, PsyD, of the Ohio State University Comprehensive Cancer Center in…
He started the No One Dies Alone programme at IMH in 2019.
(MedPage Today) -- Brain fog among individuals with sleep disorders was primarily characterized by memory impairment, difficulty concentrating, and forgetfulness, according to a lexicon analysis of…
The Cincinnati Bengals got an outstanding performance from their star quarterback on Sunday.
